blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2077127

EP2077127 - Stent coatings containing HMG-CoA reductase inhibitors [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.08.2014
Database last updated on 03.08.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Covidien LP
15 Hampshire Street
Mansfield, MA 02048 / US
[2012/50]
Former [2012/04]For all designated states
Tyco Healthcare Group, LP
15 Hampshire Street
Mansfield, MA 02048 / US
Former [2009/28]For all designated states
ev3 Peripheral, Inc.
4600 Nathan Lane North
Plymouth, MN 55442 / US
Inventor(s)01 / Pathak, Chandrashekhar
16110 Braesgate Drive
Austin, TX 78717 / US
02 / Akella, Rama
c/o ev3 Peripheral Inc.
4600 Nathan Lane North
Plymouth, Minnesota 55442 / US
03 / Ranieri, John
c/o ev3 Peripheral Inc.
4600 Nathan Lane North
Plymouth, Minnesota 55442 / US
 [2013/41]
Former [2010/14]01 / Pathak, Chandrashekhar
16110 Braesgate Drive
Austin, TX 78717 / US
02 / Akella, Rama
c/o ev3 Peripheral Inc. 4600 Nathan Lane North
Plymouth, Minnesota 55442 / US
03 / Ranieri, John
c/o ev3 Peripheral Inc. 4600 Nathan Lane North
Plymouth, Minnesota 55442 / US
Former [2009/40]01 / Pathak, Chandrashekhar
16110 Braesgate Drive
Austin, TX 78717 / US
02 / Akella, Rama
8811 Spiltarrow Drive
Austin, TX 78717 / US
03 / Ranieri, John
c/o ev3 Peripheral Inc. 4600 Nathan Lane North
Plymouth, Minnesota 55442 / US
Representative(s)Gray, James
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2013/41]Gray, James
Withers & Rogers LLP
4 More London Riverside
London
SE1 2AU / GB
Former [2012/01]Gray, James
Withers & Rogers LLP
4 More London Riverside
London
SE1 2AU / GB
Former [2009/28]Hatzmann, Martin
Vereenigde Johan de Wittlaan 7
2517 JR Den Haag / NL
Application number, filing date09155994.806.08.2002
[2009/28]
Priority number, dateUS2001099123522.10.2001         Original published format: US 991235
[2009/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2077127
Date:08.07.2009
Language:EN
[2009/28]
Type: A3 Search report 
No.:EP2077127
Date:02.06.2010
[2010/22]
Type: B1 Patent specification 
No.:EP2077127
Date:09.10.2013
Language:EN
[2013/41]
Search report(s)(Supplementary) European search report - dispatched on:EP03.05.2010
ClassificationIPC:A61L31/08, A61L31/16
[2009/28]
CPC:
A61F2/91 (EP,US); A61L31/125 (US); A61F2/82 (US);
A61L2/16 (US); A61L2/28 (US); A61L31/048 (US);
A61L31/049 (US); A61L31/06 (US); A61L31/08 (EP,US);
A61L31/10 (US); A61L31/16 (EP,US); A61F2230/0013 (EP,US);
A61F2250/0067 (EP,US); A61L2300/416 (EP,US); A61L2300/434 (EP,US);
A61L2300/602 (US); A61L2300/606 (EP,US); A61L2300/802 (US);
A61L2420/04 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2009/28]
TitleGerman:Stentbeschichtungen mit HMG-CoA-Reduktasehemmern[2009/28]
English:Stent coatings containing HMG-CoA reductase inhibitors[2009/28]
French:Revêtements d'endoprothèses contenant des inhibiteurs de la HMG-CoA réductase[2009/28]
Examination procedure24.03.2009Examination requested  [2009/28]
17.11.2010Amendment by applicant (claims and/or description)
22.07.2011Despatch of a communication from the examining division (Time limit: M04)
21.10.2011Reply to a communication from the examining division
24.04.2013Communication of intention to grant the patent
31.07.2013Fee for grant paid
31.07.2013Fee for publishing/printing paid
Parent application(s)   TooltipEP02763417.9  / EP1438084
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020763417) is  24.09.2004
Opposition(s)10.07.2014No opposition filed within time limit [2014/38]
Fees paidRenewal fee
24.03.2009Renewal fee patent year 03
24.03.2009Renewal fee patent year 04
24.03.2009Renewal fee patent year 05
24.03.2009Renewal fee patent year 06
24.03.2009Renewal fee patent year 07
25.08.2009Renewal fee patent year 08
25.08.2010Renewal fee patent year 09
25.08.2011Renewal fee patent year 10
27.08.2012Renewal fee patent year 11
27.08.2013Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.10.2013
BE09.10.2013
BG09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
MC09.10.2013
SE09.10.2013
SK09.10.2013
TR09.10.2013
GR10.01.2014
PT10.02.2014
[2016/33]
Former [2016/28]AT09.10.2013
BE09.10.2013
BG09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
MC09.10.2013
SE09.10.2013
SK09.10.2013
GR10.01.2014
PT10.02.2014
Former [2016/25]AT09.10.2013
BE09.10.2013
BG09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
MC09.10.2013
SE09.10.2013
SK09.10.2013
PT10.02.2014
Former [2015/18]AT09.10.2013
BE09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
MC09.10.2013
SE09.10.2013
SK09.10.2013
PT10.02.2014
Former [2014/41]AT09.10.2013
BE09.10.2013
CY09.10.2013
CZ09.10.2013
DK09.10.2013
EE09.10.2013
FI09.10.2013
SE09.10.2013
SK09.10.2013
PT10.02.2014
Former [2014/37]AT09.10.2013
BE09.10.2013
CY09.10.2013
CZ09.10.2013
EE09.10.2013
FI09.10.2013
SE09.10.2013
SK09.10.2013
PT10.02.2014
Former [2014/36]AT09.10.2013
BE09.10.2013
CY09.10.2013
EE09.10.2013
FI09.10.2013
SE09.10.2013
PT10.02.2014
Former [2014/28]AT09.10.2013
BE09.10.2013
CY09.10.2013
FI09.10.2013
SE09.10.2013
PT10.02.2014
Former [2014/26]AT09.10.2013
BE09.10.2013
CY09.10.2013
FI09.10.2013
SE09.10.2013
Former [2014/24]AT09.10.2013
BE09.10.2013
FI09.10.2013
SE09.10.2013
Former [2014/23]BE09.10.2013
FI09.10.2013
SE09.10.2013
Former [2014/22]FI09.10.2013
SE09.10.2013
Documents cited:Search[A]WO0062614  (NITROSYSTEMS INC [US]) [A] 1-8 * claim - *;
 [E]WO03035134  (SULZER BIOLOG INC [US]) [E] 1-8* the whole document *;
 [E]WO03039612  (DSB INVEST HOLDING SA [LU], et al) [E] 1-3,5-7 * page 2, line 12 - page 3, line 2 * * page 4, line 10 - line 16 * * page 6, line 5 - page 7, line 3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.